Application 077233

Type: ANDA
Sponsor: EXELA PHARMA SCIENCE

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	CAFFEINE CITRATE	CAFFEINE CITRATE	SOLUTION;INTRAVENOUS	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077233-001	CAFFEINE CITRATE	CAFFEINE CITRATE	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	SOLUTION / INTRAVENOUS	AP		2006-09-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A077233-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2022-10-28 04:53 UTC	2022-10	A077233-001	CAFFEINE CITRATE	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	SOLUTION / INTRAVENOUS	AP	2006-09-21	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A077233-001	CAFFEINE CITRATE	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	SOLUTION / INTRAVENOUS	AP	2006-09-21	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A077233-001	CAFFEINE CITRATE	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	SOLUTION / INTRAVENOUS	AP	2006-09-21	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A077233-001	CAFFEINE CITRATE	EQ 30MG BASE/3ML (EQ 10MG BASE/ML)	SOLUTION / INTRAVENOUS	AP	2006-09-21	`a50c72e98297…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-10-15 13:18:30	2026-09	A077233-001	AP	1	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A077233-001	AP	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077233-001	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077233-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077233-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077233-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077233-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077233-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077233-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077233-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077233-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077233-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077233-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077233-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077233-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077233-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077233-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077233-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077233-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077233-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077233-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077233-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077233-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077233-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077233-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077233-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077233-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077233-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077233-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077233-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A077233-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A077233-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A077233-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A077233-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A077233-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A077233-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A077233-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A077233-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A077233-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A077233-001	AP	1	`3a93d1ddd44b…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
caffeine citrate	CAFFEINE CITRATE	Exela Pharma Sciences, LLC	f423a220-e7bf-4d24-bc52-bafc1864265b	2015-03-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077233 application number: ANDA077233 ndc (product): 51754-0500

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 4 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
51754-0500	caffeine citrate	caffeine citrate	Exela Pharma Sciences, LLC	ANDA	Current
51754-0500	caffeine citrate	caffeine citrate	Exela Pharma Sciences, LLC	ANDA	Current
51754-0502	caffeine citrate	CAFFEINE CITRATE	Exela Pharma Sciences, LLC	ANDA	Current
51754-0502	caffeine citrate	CAFFEINE CITRATE	Exela Pharma Sciences, LLC	ANDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
9021	ORIG	2006-09-25